These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9886388

  • 1. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets.
    Erard F, Garcia-Sanz JA, Moriggl R, Wild MT.
    J Immunol; 1999 Jan 01; 162(1):209-14. PubMed ID: 9886388
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S, Seelig M, Lee HM, Lin J.
    J Immunol; 1995 Jul 15; 155(2):609-18. PubMed ID: 7608539
    [Abstract] [Full Text] [Related]

  • 3. Differential activation of CD8+ T cells by transforming growth factor-beta 1.
    Lee HM, Rich S.
    J Immunol; 1993 Jul 15; 151(2):668-77. PubMed ID: 8335902
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype.
    Swain SL, Huston G, Tonkonogy S, Weinberg A.
    J Immunol; 1991 Nov 01; 147(9):2991-3000. PubMed ID: 1680924
    [Abstract] [Full Text] [Related]

  • 5. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
    Gray JD, Hirokawa M, Ohtsuka K, Horwitz DA.
    J Immunol; 1998 Mar 01; 160(5):2248-54. PubMed ID: 9498764
    [Abstract] [Full Text] [Related]

  • 6. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I, Kohno K, Tanimoto T, Ikegami H, Kurimoto M.
    J Immunol; 1999 Mar 15; 162(6):3202-11. PubMed ID: 10092771
    [Abstract] [Full Text] [Related]

  • 7. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.
    Liu SJ, Tsai JP, Shen CR, Sher YP, Hsieh CL, Yeh YC, Chou AH, Chang SR, Hsiao KN, Yu FW, Chen HW.
    J Leukoc Biol; 2007 Aug 15; 82(2):354-60. PubMed ID: 17505023
    [Abstract] [Full Text] [Related]

  • 8. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T, Streilein JW.
    Invest Ophthalmol Vis Sci; 2000 Jun 15; 41(7):1803-11. PubMed ID: 10845601
    [Abstract] [Full Text] [Related]

  • 9. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML, Chen HW, Tsai JP, Lee YP, Shih YC, Chang CM, Ting CC.
    J Leukoc Biol; 2006 May 15; 79(5):1033-42. PubMed ID: 16478921
    [Abstract] [Full Text] [Related]

  • 10. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, Elflein K, Hünig T, Mittrücker HW, Brüstle A, Kamradt T, Lohoff M.
    Eur J Immunol; 2009 Jul 15; 39(7):1716-25. PubMed ID: 19544308
    [Abstract] [Full Text] [Related]

  • 11. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T, Inoue T, Sugimoto A, Motoda R, Yamasaki F, Nakamura S, Kibata M.
    Exp Hematol; 2008 Feb 15; 36(2):181-92. PubMed ID: 18023521
    [Abstract] [Full Text] [Related]

  • 12. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
    Rodolfo M, Zilocchi C, Accornero P, Cappetti B, Arioli I, Colombo MP.
    J Immunol; 1999 Aug 15; 163(4):1923-8. PubMed ID: 10438927
    [Abstract] [Full Text] [Related]

  • 13. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
    Inge TH, McCoy KM, Susskind BM, Barrett SK, Zhao G, Bear HD.
    J Immunol; 1992 Jun 15; 148(12):3847-56. PubMed ID: 1602133
    [Abstract] [Full Text] [Related]

  • 14. IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes.
    Lai YG, Gelfanov V, Gelfanova V, Kulik L, Chu CL, Jeng SW, Liao NS.
    J Immunol; 1999 Dec 01; 163(11):5843-50. PubMed ID: 10570268
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I, König B, Böttcher I, Knop J, Saloga J.
    Clin Exp Allergy; 2006 Dec 01; 36(12):1546-55. PubMed ID: 17177678
    [Abstract] [Full Text] [Related]

  • 16. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
    Smyth MJ, Strobl SL, Young HA, Ortaldo JR, Ochoa AC.
    J Immunol; 1991 May 15; 146(10):3289-97. PubMed ID: 1827481
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
    Dumont FJ, Kastner CA.
    J Cell Physiol; 1994 Jul 15; 160(1):141-53. PubMed ID: 8021294
    [Abstract] [Full Text] [Related]

  • 18. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, Todd I, Powell RJ.
    J Autoimmun; 2001 Sep 15; 17(2):155-63. PubMed ID: 11591124
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of type I IFNs on the growth of WC1- CD8+ gamma delta T cells and WC1+ CD8- gamma delta T cells in vitro.
    Tuo W, Bazer FW, Davis WC, Zhu D, Brown WC.
    J Immunol; 1999 Jan 01; 162(1):245-53. PubMed ID: 9886392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.